Cargando…

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic

Background: The coronavirus disease pandemic of 2019 (COVID-19) has been associated with coagulopathy and an increased rate of thrombosis in adults. Medical practitioners have been prompted to consider prophylactic anticoagulation in special populations diagnosed with COVID-19. Patients with sickle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davila, Jennifer G., Mitchell, W. Beau, Morrone, Kerry A, Silver, Ellen J, Minniti, Caterina P, Billett, Henny H., Desai, Payal, O'Brien, Sarah H., Manwani, Deepa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	114.Hemoglobinopathies, Excluding Thalassemia-Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330277/ http://dx.doi.org/10.1182/blood-2020-137071

Ejemplares similares

Excess All-Cause Mortality in 2020 for People Living with Sickle Cell Disease in New York City
por: Curtis, Susanna A, et al.
Publicado: (2021)

Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
por: Sewaralthahab, Sarah, et al.
Publicado: (2020)

Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection
por: Mucalo, Lana, et al.
Publicado: (2020)

Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection
por: Merz, Lauren E., et al.
Publicado: (2020)

Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic
por: Nowlin, Andrea, et al.
Publicado: (2020)

Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease
por: Abdelaal, Mahmoud A.Z., et al.
Publicado: (2020)

Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina
por: Noisette, Laurence, et al.
Publicado: (2020)

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome
por: Tanenbaum, Mira T, et al.
Publicado: (2019)

COVID-19 in Hospitalized Patients with Sickle Cell Disease
por: Guarino, Stephanie, et al.
Publicado: (2021)

Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS)
por: Lam, Ho Pui Jeff, et al.
Publicado: (2020)

COVID-19 Infection and Outcomes at a Comprehensive Sickle Cell Center
por: El Rassi, Fuad, et al.
Publicado: (2021)

Sickle Cell Disease and COVID-19 Infection: A Single-Center Experience
por: Devarashetty, Sindhu, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Acute Care Visits for Patients with Sickle Cell Disease
por: Orkoulas-Razis, Dennis, et al.
Publicado: (2021)

Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study
por: Konté, Kadère, et al.
Publicado: (2021)

Sickle Cell Disease (SCD) As a Risk for COVI19 Compared to Those without SCD Among Patients Admitted in a Large Urban Center, As Estimated By PCR Sars-v-2 Positive Vs Negative Testing
por: Adamkiewicz, Tom, et al.
Publicado: (2021)

Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
por: Rao, Shivani, et al.
Publicado: (2021)

Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
por: Rao, Shivani, et al.
Publicado: (2021)

Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease
por: Tarasev, Michael, et al.
Publicado: (2021)

Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality
por: Grosse, Scott D., et al.
Publicado: (2011)

Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease
por: Anusim, Nwabundo, et al.
Publicado: (2020)

Lateral Elbow Tendinopathy: Development of a Pathophysiology-Based Treatment Algorithm
por: Bhabra, Gev, et al.
Publicado: (2016)

Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report
por: Alghamdi, Badria M., et al.
Publicado: (2020)

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic
por: De Luna, Gonzalo, et al.
Publicado: (2020)

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021)

Profiling Dose-Dependent Activation of p53-Mediated Signaling Pathways by Chemicals with Distinct Mechanisms of DNA Damage
por: Clewell, Rebecca A., et al.
Publicado: (2014)

Radiostereometric Evaluation of Tendon Elongation After Distal Biceps Repair
por: Marshall, Nathan E., et al.
Publicado: (2016)

Spanish Consensus Statement: Clinical Management and Treatment of Tendinopathies in Sport
por: Fernandez-Jaén, Tomas, et al.
Publicado: (2017)

Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients
por: Davila, Jennifer, et al.
Publicado: (2022)

Intérêt d’une dose unique de Tocilizumab 400 mg sur les formes sévères d’infection respiratoire à COVID-19
por: Rossi, B., et al.
Publicado: (2020)

Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults
por: Mitchell, William Beau, et al.
Publicado: (2020)

Immunothérapie dans le mélanome en hospitalisation à domicile : enquête de satisfaction et retour d’expérience des centres français d’oncodermatologie
por: Truong, Thao, et al.
Publicado: (2021)

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Comorbidities in sickle cell disease: Adult providers needed!
por: Ogu, Ugochi O., et al.
Publicado: (2018)

Heterogeneity of βs gene haplotypes in patients with sickle cell disease (SCD) in Oman: A review of relevant publications
por: Al-Mashaikhi, Nawal, et al.
Publicado: (2022)

Excess deaths among adults with sickle cell disease in 2020 compared to prior years
por: Curtis, Susanna, et al.
Publicado: (2022)

Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - a fifteen hospital observational study in the Bronx, New York
por: Hoogenboom, Wouter S., et al.
Publicado: (2021)

Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature
por: Hoogenboom, Wouter S., et al.
Publicado: (2022)

The Effects of Treatment with Blood Transfusion, Iron Chelation and Hydroxyurea on Puberty, Growth and Spermatogenesis in Sickle Cell Disease (SCD): A short update
por: Soliman, Ashraf T, et al.
Publicado: (2021)

Blood transfusion and iron overload in patients with Sickle Cell Disease (SCD): Personal experience and a short update of diabetes mellitus occurrence
por: Soliman, Ashraf T, et al.
Publicado: (2022)

Ambulatory Hypertension in Pediatric Patients With Sickle Cell Disease and Its Association With End-Organ Damage
por: Ranabothu, Saritha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qtn9epfrdud3klu7a5jl0gi34n